Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02045017
What this trial is testing

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

Who this might be right for
Multiple Myeloma
Celgene 81
Large-scale testing (Phase 3)Looking for participantsNCT03619850
What this trial is testing

Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease; Iron Deficiency Anemia
AMAG Pharmaceuticals, Inc. 129
Early research (Phase 1)Study completedNCT02661126
What this trial is testing

Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 16
Early research (Phase 1)Study completedNCT05865171
What this trial is testing

Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment

Who this might be right for
Renal Impairment
Vertex Pharmaceuticals Incorporated 16
Early research (Phase 1)UnknownNCT05731804
What this trial is testing

Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir

Who this might be right for
Renal ImpairmentHepatic Impairment
Jiangsu Simcere Pharmaceutical Co., Ltd. 72
Testing effectiveness (Phase 2)Study completedNCT00646932
What this trial is testing

Paricalcitol Injection Phase II Trial

Who this might be right for
Chronic Kidney Disease
Abbott 25
Post-approval studies (Phase 4)Not Yet RecruitingNCT07116928
What this trial is testing

Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)CKD - Chronic Kidney Disease
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 1,244
Early research (Phase 1)Study completedNCT02431481
What this trial is testing

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

Who this might be right for
Normal Renal FunctionImpaired Renal Function
Novartis Pharmaceuticals 38
Post-approval studies (Phase 4)UnknownNCT02590081
What this trial is testing

Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients

Who this might be right for
End-Stage Kidney DiseaseHemodialysis
Penang Hospital, Malaysia 434
Early research (Phase 1)Study completedNCT02002767
What this trial is testing

Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment

Who this might be right for
Hepatitis C Virus
Gilead Sciences 19
Early research (Phase 1)Study completedNCT01512667
What this trial is testing

Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)

Who this might be right for
Renal Insufficiency
Merck Sharp & Dohme LLC 25
Testing effectiveness (Phase 2)Study completedNCT01587924
What this trial is testing

4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anaemia
GlaxoSmithKline 80
Early research (Phase 1)Study completedNCT01711723
What this trial is testing

Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment

Who this might be right for
Atherosclerosis
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT02509624
What this trial is testing

Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function

Who this might be right for
Diabetic Kidney Disease
Gilead Sciences 52
Testing effectiveness (Phase 2)Ended earlyNCT04987294
What this trial is testing

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Who this might be right for
HyperuricemiaGoutChronic Kidney Diseases
Allena Pharmaceuticals 19
Large-scale testing (Phase 3)Study completedNCT01932970
What this trial is testing

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 158
Early research (Phase 1)WithdrawnNCT03630029
What this trial is testing

RBT-1 Phase 1b Clinical Trial in Healthy Volunteers and Subjects With CKD

Who this might be right for
Acute Kidney Injury
Renibus Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT00526929
What this trial is testing

Fixed Dose NESP Study in Subjects With CRI

Who this might be right for
Pre-Dialysis
Amgen 75
Early research (Phase 1)Study completedNCT00759564
What this trial is testing

Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function

Who this might be right for
Pneumonia
Pfizer 29
Early research (Phase 1)Study completedNCT04176536
What this trial is testing

A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body

Who this might be right for
HealthyChronic Kidney Disease
Boehringer Ingelheim 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation